Prevalence and predictive modeling of undiagnosed diabetes and impaired fasting glucose in Taiwan: a Taiwan Biobank study

被引:4
|
作者
Chung, Ren-Hua [1 ]
Chuang, Shao-Yuan [1 ]
Chen, Ying-Erh [2 ]
Li, Guo-Hung [1 ]
Hsieh, Chang-Hsun [3 ]
Chiou, Hung-Yi [1 ,4 ]
Hsiung, Chao A. [1 ]
机构
[1] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan
[2] Tamkang Univ, Dept Risk Management & Insurance, Taipei, Taiwan
[3] Triserv Gen Hosp, Div Endocrinol & Metab, Dept Internal Med, Natl Def Med Ctr, Taipei, Taiwan
[4] Taipei Med Univ, Coll Publ Hlth, Sch Publ Hlth, Taipei, Taiwan
关键词
risk assessment; pre-diabetic state; early diagnosis; RISK SCORE; TYPE-2; PREVENTION;
D O I
10.1136/bmjdrc-2023-003423
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionWe investigated the prevalence of undiagnosed diabetes and impaired fasting glucose (IFG) in individuals without known diabetes in Taiwan and developed a risk prediction model for identifying undiagnosed diabetes and IFG.Research design and methodsUsing data from a large population-based Taiwan Biobank study linked with the National Health Insurance Research Database, we estimated the standardized prevalence of undiagnosed diabetes and IFG between 2012 and 2020. We used the forward continuation ratio model with the Lasso penalty, modeling undiagnosed diabetes, IFG, and healthy reference group (individuals without diabetes or IFG) as three ordinal outcomes, to identify the risk factors and construct the prediction model. Two models were created: Model 1 predicts undiagnosed diabetes, IFG_110 (ie, fasting glucose between 110 mg/dL and 125 mg/dL), and the healthy reference group, while Model 2 predicts undiagnosed diabetes, IFG_100 (ie, fasting glucose between 100 mg/dL and 125 mg/dL), and the healthy reference group.ResultsThe standardized prevalence of undiagnosed diabetes for 2012-2014, 2015-2016, 2017-2018, and 2019-2020 was 1.11%, 0.99%, 1.16%, and 0.99%, respectively. For these periods, the standardized prevalence of IFG_110 and IFG_100 was 4.49%, 3.73%, 4.30%, and 4.66% and 21.0%, 18.26%, 20.16%, and 21.08%, respectively. Significant risk prediction factors were age, body mass index, waist to hip ratio, education level, personal monthly income, betel nut chewing, self-reported hypertension, and family history of diabetes. The area under the curve (AUC) for predicting undiagnosed diabetes in Models 1 and 2 was 80.39% and 77.87%, respectively. The AUC for predicting undiagnosed diabetes or IFG in Models 1 and 2 was 78.25% and 74.39%, respectively.ConclusionsOur results showed the changes in the prevalence of undiagnosed diabetes and IFG. The identified risk factors and the prediction models could be helpful in identifying individuals with undiagnosed diabetes or individuals with a high risk of developing diabetes in Taiwan.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Prevalence of Diabetes Mellitus, Impaired Fasting Glucose, and Impaired Glucose Tolerance in Thalassemia Major in Tabriz
    Najafipour, Mostafa
    Zareizadeh, Masoumeh
    Najafipour, Farzad
    ASIAN JOURNAL OF PHARMACEUTICS, 2018, 12 (02) : S615 - S618
  • [22] Prevalence of diabetes, impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) in Sri Lanka - Sri Lanka diabetes and cardiovascular study
    Katulanda, Prasad
    Constantine, Godwin R.
    Sheriff, Rezvi
    McCarthy, Mark I.
    Seneviratne, Rohini D.
    Matthews, David R.
    DIABETES, 2007, 56 : A249 - A249
  • [23] The Relationship of Hepatitis Antibodies and Elevated Liver Enzymes with Impaired Fasting Glucose and Undiagnosed Diabetes
    Mainous, Arch G.
    Diaz, Vanessa A.
    King, Dana E.
    Everett, Charles J.
    Player, Marty S.
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2008, 21 (06) : 497 - 503
  • [24] Undiagnosed impaired fasting glucose and diabetes mellitus amongst inpatients receiving antipsychotic drugs
    Taylor, D
    Young, C
    Mohamed, R
    Paton, C
    Walwyn, R
    JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (02) : 182 - 186
  • [25] The Relationship of Hepatitis Antibodies and Elevated Liver Enzymes with Impaired Fasting Glucose and Undiagnosed Diabetes
    Cox-North, Paula P.
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2009, 22 (03) : 339 - 339
  • [26] High prevalence of diabetes and impaired fasting glucose in urban Latin America: the CARMELA Study
    Escobedo, J.
    Buitron, L. V.
    Velasco, M. F.
    Ramirez, J. C.
    Hernandez, R.
    Macchia, A.
    Pellegrini, F.
    Schargrodsky, H.
    Boissonnet, C.
    Champagne, B. M.
    DIABETIC MEDICINE, 2009, 26 (09) : 864 - 871
  • [27] Prevalence of impaired fasting glucose, type 2 diabetes and associated risk factors in undiagnosed Chinese rural population: the Henan Rural Cohort Study
    Abdulai, Tanko
    Li, Yuqian
    Zhang, Haiqing
    Tu, Runqi
    Liu, Xiaotian
    Zhang, Liying
    Dong, Xiaokang
    Li, Ruiying
    Wang, Yuming
    Wang, Chongjian
    BMJ OPEN, 2019, 9 (08):
  • [28] Gestational diabetes, prevalence of metabolic syndrome, impaired fasting glucose and progression to diabetes
    Kimball-Ravari, L
    Djedjos, S
    Bejjanki, S
    Behm, T
    Ali, W
    Ton, A
    Yaturu, S
    DIABETES, 2005, 54 : A676 - A676
  • [29] Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population
    Guerrero-Romero, Fernando
    Violante, Rafael
    Rodriguez-Moran, Martha
    PAEDIATRIC AND PERINATAL EPIDEMIOLOGY, 2009, 23 (04) : 363 - 369
  • [30] Prevalence of undiagnosed type 2 diabetes, impaired fasting glucose and associated risk factors in first generation Korean-Americans
    Kim, PJ
    Yun, HS
    Kim, KH
    Lee, AC
    Min, DF
    Lorber, DL
    DIABETES, 2001, 50 : A479 - A479